Part of NIH’s STRIVE consortium, the therapeutic may prevent overactive immune systems from causing severe symptoms.
Pr Press Articles, Journals and News
Latest News
Ohio State research, expertise on display at Farm Science Review
The 2023 Ohio State University’s Farm Science Review, the 61st expo highlighting agricultural innovations, concluded its three-day run at the Molly Caren Agricultural Center in London, Ohio, this week. The annual show, presented by the College of Food, Agricultural, and Environmental Sciences (CFAES), attracts over 100,000 visitors from across the United States and Canada.
NIH researchers develop new method to identify potential stroke therapies
First-of-its-kind study points to uric acid as a promising treatment for further investigation.
Researchers discover biomarker for tracking depression recovery
New deep brain stimulation device coupled with powerful AI may improve therapy for treatment-resistant depression.
Clinical trial of HIV vaccine begins in United States and South Africa
Novel vaccine includes NIH-funded technology in development since 2004.
Techstars and The Ohio State University launch accelerator program for entrepreneurs advancing software innovation
Techstars, the largest pre-seed investor in the world, and The Ohio State University are partnering to bring a new accelerator program to drive growth in Columbus and the greater region by investing in the most promising software startups and innovators.
Roads Scholar Tour connects Ohio State with Columbus community
The 2023 Roads Scholar Tour, held Friday by The Ohio State University Office of Outreach and Engagement, promoted the ongoing dialogue between the university and community partners throughout Columbus.
Yogurt may be the next go-to garlic breath remedy
It turns out yogurt may have a previously unknown benefit: eliminating garlic odors.
Urban Arts Space celebrates inaugural community artist-in-residence Arris’ J. Cohen
The Ohio State University’s Urban Arts Space (UAS) has named Arris’ J. Cohen as the center’s inaugural community artist-in-residence.
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl.
